These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1767784)

  • 21. [Anticholinergic therapy of urinary incontinence and urinary frequency associated with the elderly--with special reference to dementia].
    Sugiyama T; Matsuda H; Oonishi N; Kiwamoto H; Esa A; Park YC; Kurita T; Uchida A; Kunikata S
    Nihon Hinyokika Gakkai Zasshi; 1993 Jun; 84(6):1068-73. PubMed ID: 8345723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Terodiline in the treatment of urinary frequency and motor urge incontinence. A controlled multicentre trial.
    Peters D
    Scand J Urol Nephrol Suppl; 1984; 87():21-33. PubMed ID: 6399953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Propiverine hydrochloride improved correlatively subjective QOL and objective findings in Japanese patients with urinary frequency and/or incontinence].
    Noguchi K; Yamagishi T; Suzuki K; Kondo K; Kishida T; Saito K; Sekiguchi Y; Nakaigawa N; Ogawa T; Uemura H; Yao M; Kubota Y; Kawai M; Okajima K; Kobayashi K; Moriyama M; Kinoshita Y; Mikata K; Kitami K; Masuda M; Saito R; Murai T; Tomoda T; Noguchi S; Sakai N; Hamano A; Nomura S; Sato K
    Hinyokika Kiyo; 2006 May; 52(5):343-8. PubMed ID: 16758722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical study of voiding disorders in patients with cerebrovascular accidents].
    Murayama K; Katsumi T; Ikeda M; Ishikura A
    Hinyokika Kiyo; 1991 Oct; 37(10):1243-8. PubMed ID: 1755418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of functional continuous magnetic stimulation for urinary incontinence.
    Yamanishi T; Yasuda K; Suda S; Ishikawa N; Sakakibara R; Hattori T
    J Urol; 2000 Feb; 163(2):456-9. PubMed ID: 10647653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of bunazosin hydrochloride for the treatment of voiding disturbances due to neurogenic bladder--a double-blind study].
    Koyanagi T; Togashi M; Maru A; Orikasa S; Soma F; Shimazaki J; Yasuda K; Aso Y; Honma Y; Miyake K
    Hinyokika Kiyo; 1990 Oct; 36(10):1233-52. PubMed ID: 1979900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experimental and clinical evaluation of functional electrical stimulation of the anal sphincter].
    Yokoyama O; Miyazaki K; Ishida T; Nango O; Fujita Y; Nagano K; Kawaguchi K; Koshida K; Hisazumi H
    Hinyokika Kiyo; 1992 Oct; 38(10):1109-15. PubMed ID: 1481771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of the cerebro-metabolism activator (bifemelane hydrochloride) on urinary incontinence and pollakisuria associated with cerebrovascular dementia].
    Sugiyama T; Matuda H; Ohnishi N; Kiwamoto H; Esa A; Park YC; Kurita T; Uchida A; Kunikata S
    Hinyokika Kiyo; 1991 Mar; 37(3):249-54. PubMed ID: 2069105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Assessment of the use of oxybutynin hydrochloride (Pollakisu tablets) in the elderly].
    Uchibayashi T; Nakajima K; Nihino A; Hisazumi H
    Hinyokika Kiyo; 1991 Sep; 37(9):1077-85. PubMed ID: 1785418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical effects of oxybutynin hydrochloride on neurogenic bladder].
    Toma H; Nakamura R
    Hinyokika Kiyo; 1986 Jun; 32(6):907-11. PubMed ID: 3532726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A symptomatic and cystometric comparison of terodiline with emepronium in the treatment of women with frequency, urgency and incontinence.
    Sole GM; Arkell DG
    Scand J Urol Nephrol Suppl; 1984; 87():55-7. PubMed ID: 6399955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical effects of oxybutynin hydrochloride in the treatment of unstable bladder and overactive neurogenic bladder: a long-term clinical trial].
    Goto M; Kato K; Kondo A; Otani T; Takita T; Kobayashi M
    Hinyokika Kiyo; 1988 Mar; 34(3):541-50. PubMed ID: 3389295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical effect of terodiline hydrochloride (TD-758) in patients with urinary disturbances].
    Nakano M; Tajima A; Aso Y; Suzuki K; Hata M; Tsukada T; Masuda H; Hirose J; Kitagawa M; Nakahara M
    Hinyokika Kiyo; 1988 Jan; 34(1):196-200. PubMed ID: 3376801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Urethral instability: diagnosis and clinical significance].
    Penders L; de Leval J; Petit R
    J Urol (Paris); 1984; 90(6):385-93. PubMed ID: 6520409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of the symptoms of urinary urge and urge incontinence with propiverin hydrochloride (Mictonorm)].
    Blau U; Retzke U
    Zentralbl Gynakol; 1984; 106(14):981-7. PubMed ID: 6506904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A controlled, double-blind, cross-over study of terodiline in motor urge incontinence.
    Lukkarinen O; Gröhn P; Wilén-Rosenqvist G; Juusela H; Sotarauta M; Lehtonen T
    Ann Chir Gynaecol; 1987; 76(2):128-32. PubMed ID: 3304118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of terodiline treatment in women with motor urge incontinence. Results from a double-blind study and long-term treatment.
    Ulmsten U; Ekman G; Andersson KE
    Am J Obstet Gynecol; 1985 Nov; 153(6):619-22. PubMed ID: 2998191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
    Schurch B; de Sèze M; Denys P; Chartier-Kastler E; Haab F; Everaert K; Plante P; Perrouin-Verbe B; Kumar C; Fraczek S; Brin MF;
    J Urol; 2005 Jul; 174(1):196-200. PubMed ID: 15947626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical efficacy of clenbuterol and propiverine in menopausal women with urinary incontinence: improvement in quality of life.
    Ushiroyama T; Ikeda A; Ueki M
    J Med; 2000; 31(5-6):311-9. PubMed ID: 11508324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The use of intravesical oxybutynin hydrochloride in patients with neurogenic bladder managed by intermittent catheterization].
    Yokoyama O; Ishiura Y; Nakamura Y; Ohkawa M
    Hinyokika Kiyo; 1995 Jul; 41(7):521-4. PubMed ID: 7668182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.